Revaclear dialyzer
#1
#2
#3
#4
Vantive, AK 98, Polyflux, Poracton, Revaclear and Theranova are trademarks of Vantive Health LLC or its affiliates.
References
-
Ronco C, Crepaldi C, Brendolan A, et al. Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol Dial Transplant. 2003;18(Suppl 7):vii10-20.
-
Ward R, Ouseph R. Modification of membrane characteristics allows a reduction in dialyzer membrane area without loss of performance. Abstract SA-PO510, presented at the 40th American Society of Nephrology (ASN) Congress. San Francisco, USA, 2007.
-
Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and beta2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant. 2010;25:3990-3995.
-
Mauric A, et al. Poster SP401, presented at 50th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress. Istanbul (Turkey), 2013.
-
Vantive Health LLC. Revaclear White Paper. USMP/MG3/140052, May 2013.